Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology, admits that he was once “oblivious” to his patients’ concerns about the cost of cancer treatment. However, it is important for clinicians to empathize with these fears and understand how they can factor into a patient’s care choices.
Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology, admits that he was once “oblivious” to his patients’ concerns about the cost of cancer treatment. However, it is important for clinicians to empathize with these fears and understand how they can factor into a patient’s care choices.
Transcript (slightly modified)
How does cost sharing influence outcomes in oncology?
This is a fascinating question, because I’ll tell you that for years, actually decades, patients have asked me, “What does this cost?” And I’ve been completely oblivious to that answer. And over the last 5 years I’ve realized that me being oblivious to the cost of care was inadequate because for some patients, this idea that either through tiered co-payments or even through co-insurance, that part of the cost of that care, which could in fact be quite substantial, was theirs, was going to be borne by them.
So when we look at a lot of healthcare coverage these days, that deductible factors very deeply into a patient’s care choices, into how they view different options offered to them. And this idea that patients can live with the fear of financial devastation and bankruptcy as part of their healthcare experience is something that has to give us a certain sense of humility, has to give us a certain sense of pause, and also I think forces us as practitioners to assume greater ownership over these sorts of ideas, which is something that frankly I hadn’t done previously.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More